UTHR - United Therapeutics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.82B
Enterprise Value 34.2B
Trailing P/E 11.98
Forward P/E 110.86
PEG Ratio (5 yr expected) 1-0.55
Price/Sales (ttm)2.79
Price/Book (mrq)2.29
Enterprise Value/Revenue 32.44
Enterprise Value/EBITDA 63.98

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 24.22%
Operating Margin (ttm)59.40%

Management Effectiveness

Return on Assets (ttm)24.61%
Return on Equity (ttm)21.14%

Income Statement

Revenue (ttm)1.73B
Revenue Per Share (ttm)39.21
Quarterly Revenue Growth (yoy)13.60%
Gross Profit (ttm)1.62B
EBITDA 1.06B
Net Income Avi to Common (ttm)417.9M
Diluted EPS (ttm)9.31
Quarterly Earnings Growth (yoy)-82.80%

Balance Sheet

Total Cash (mrq)927.4M
Total Cash Per Share (mrq)21.45
Total Debt (mrq)250M
Total Debt/Equity (mrq)11.90
Current Ratio (mrq)3.26
Book Value Per Share (mrq)48.61

Cash Flow Statement

Operating Cash Flow (ttm)474.2M
Levered Free Cash Flow (ttm)618.84M

Trading Information

Stock Price History

Beta 1.20
52-Week Change 3-6.31%
S&P500 52-Week Change 311.79%
52 Week High 3152.55
52 Week Low 3106.30
50-Day Moving Average 3111.68
200-Day Moving Average 3125.48

Share Statistics

Avg Vol (3 month) 3445.6k
Avg Vol (10 day) 3387.1k
Shares Outstanding 543.24M
Float 42.49M
% Held by Insiders 11.69%
% Held by Institutions 1103.11%
Shares Short 35.97M
Short Ratio 314.89
Short % of Float 314.99%
Shares Short (prior month) 35.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Sep 23, 2009